Regarding the polymerase chain reaction (PCR)-based method, IMP3 has been used as a molecular marker to predict peritoneal recurrence following curative surgery for gastric cancer (11), and PCR amplification of IMP3 from biliary structure specimens have been useful to distinguish between benign and malignant lesions (29). The gene discussed is IMP3; the disease is gastric cancer.